Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)

China flag China · Delayed Price · Currency is CNY
16.67
-0.14 (-0.83%)
Apr 30, 2026, 1:55 PM CST
21.24%
Market Cap 5.18B
Revenue (ttm) 1.35B
Net Income (ttm) 412.89M
Shares Out 308.12M
EPS (ttm) 1.34
PE Ratio 12.51
Forward PE n/a
Dividend 1.00 (5.95%)
Ex-Dividend Date Apr 28, 2026
Volume 2,280,385
Average Volume 6,465,170
Open 21.90
Previous Close 16.81
Day's Range 16.60 - 21.90
52-Week Range 13.43 - 23.98
Beta 0.13
RSI 29.69
Earnings Date Apr 24, 2026

About SHE:002393

Tianjin Lisheng Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company offers pharmaceutical, traditional Chinese medicine, and antibiotic products in various forms, such as oral solid dosage forms, soft capsules, sterile preparations, and raw materials primarily for cardiovascular and digestive system applications. Its products also include Shoubishan capsules, Jiayindapamide tablets, Sanyu Zhengtong tablets, Xifuni cefdinir dispersible tablets,... [Read more]

Sector Healthcare
Founded 1951
Employees 1,605
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002393
Full Company Profile

Financial Performance

In 2025, SHE:002393's revenue was 1.39 billion, an increase of 4.18% compared to the previous year's 1.34 billion. Earnings were 416.28 million, an increase of 125.59%.

Financial Statements

News

There is no news available yet.